Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Trial of Fluvoxamine for Melancholia

NCT04160377 is registered in ClinicalTrials.gov with Lingjiang Li as lead sponsor.

NCT NCT04160377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04160377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Trial of Fluvoxamine for Melancholia
Lead sponsor
Lingjiang Li
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2019
Completion date
September 30, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, endogenous depression, melancholia